Ronald Realubit

Columbia University Irving Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.9kcitations160works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(52), Bioinformatics and Genomic Networks(34), Computational Drug Discovery Methods(33), Protein Degradation and Inhibitors(22), Ubiquitin and proteasome pathways(21)

Publications160 total

Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Index of Supplementary Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S3 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S2 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Supplementary Figures S1-S11 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S1 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S4 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S7 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S6 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S5 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

2025Open Access

Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor

2025Open Access

page 1 of 8Next →

Frequent Co-authors

Charles Karan(46), Andrea Califano(31), Mariano J. Alvarez(24), Gary K. Schwartz(15), Eugene F. Douglass(15), Richard D. Carvajal(14), Adina Grunn(13), Daniel Diolaiti(13), Andrew L. Kung(13), Prabhjot S. Mundi(12), Hanina Hibshoosh(12), Mahalaxmi Aburi(11), Filemon S. Dela Cruz(11), Peter A. Sims(11), Kenneth P. Olive(11), Jeffrey N. Bruce(11), Peter Canoll(11), Allison R. Rainey(10), Audrey Mauguen(10), Kristina Guillan(10)